Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

Healthcare Cannabis

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp > Canopy Growth sues GW Pharma for CO2 Extraction

<< Previous

Bullboard Posts

Next >>

Comment by lscfaon Dec 24, 2020 7:11pm

190 Views

Post# 32181971

RE:RE:Canopy Growth sues GW Pharma for CO2 Extraction

e.g. a patent from 1982......

https://patents.google.com/patent/US4554170A/en

lscfa wrote: Canopy will fail. Since the technology has been around since the mid-1980s Canopy's 2000 patent is worthless as it was obvious in 2000 that Supercritical CO2 Fluid Extraction could be applied to hemp and cannabis. Good thing Canopy only paid $1.00 for it.

For GW Pharmaceuticals to win, the company will have to demonstrate that its method, described in broad terms on its website, uses technology not claimed in Canopy’s patent—or that the technology that Canopy’s new patent claims were “known or obvious” in 2000, when the patent application was filed.

<< Previous

Bullboard Posts

Next >>

Canadian artificial intelligence ETFs